Dopamine D3 receptor ligands for the treatment of tobacco dependence.
about
Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug developmentThe dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.Structure-activity relationships for a novel series of dopamine D2-like receptor ligands based on N-substituted 3-aryl-8-azabicyclo[3.2.1]octan-3-ol.Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs.Effects of chronic buspirone treatment on nicotine and concurrent nicotine+cocaine self-administration.Vaccination against nicotine: an emerging therapy for tobacco dependence.Mechanism-based medication development for the treatment of nicotine dependence.Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.Effects of nicotine in experimental animals and humans: an update on addictive properties[Future medications for tobacco and cannabis dependence].Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNOElevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humansEffects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord.Direct and indirect interactions of the dopamine D₃ receptor with glutamate pathways: implications for the treatment of schizophrenia.The effects of buspirone on occupancy of dopamine receptors and the rat gambling task.
P2860
Q27014737-59E2D375-2317-4D5B-98C8-50B41854619DQ33992366-79C595F8-2998-4103-90F4-7B45946D67F0Q35143623-DF9ABC95-A5F0-472D-9981-A7EA7D6C2BD6Q35168503-5FCBD1B6-62C7-4DB6-B3FF-BDD039B33B32Q35962024-3B18F8B8-4841-441E-BBC8-162725CFB392Q36850568-975350CD-ABBF-4D70-9596-EA34712A0010Q36985864-0E013EDE-1CC8-488A-8487-A346560259C6Q37018610-B96E77B0-E754-4412-9994-9C71F77B6949Q37079797-6313632C-56F0-48C9-98F1-A108097829DCQ37203879-31251C53-6B39-4202-8158-527E33BD70E6Q37347842-401E2262-FD7B-4228-AFD4-4F30909D314EQ37409577-915FBB47-9C16-4BD2-B31B-CFD5CD96FCB5Q37409589-C3A9E15F-02B3-4F28-BA1A-A38BEF8D377BQ37642452-1F839E48-C409-46CE-A7EB-A721EAF57F96Q40555581-EB5DCFEB-8232-4762-A300-57FBC29A51E5Q43068454-D341B694-FAA1-43EC-A21C-53A6A3D9004DQ47642105-D9877194-B61B-46AD-B2C2-78EDE8CCD909
P2860
Dopamine D3 receptor ligands for the treatment of tobacco dependence.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Dopamine D3 receptor ligands for the treatment of tobacco dependence.
@ast
Dopamine D3 receptor ligands for the treatment of tobacco dependence.
@en
type
label
Dopamine D3 receptor ligands for the treatment of tobacco dependence.
@ast
Dopamine D3 receptor ligands for the treatment of tobacco dependence.
@en
prefLabel
Dopamine D3 receptor ligands for the treatment of tobacco dependence.
@ast
Dopamine D3 receptor ligands for the treatment of tobacco dependence.
@en
P2093
P2860
P356
P1476
Dopamine D3 receptor ligands for the treatment of tobacco dependence.
@en
P2093
Bernard Le Foll
Pierre Sokoloff
Steven R Goldberg
P2860
P356
10.1517/13543784.16.1.45
P407
P577
2007-01-01T00:00:00Z